Position
Creative Planning in Oric Pharmaceuticals, Inc.
Back to the book · All holders of ORIC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $66.3K$8.18 → $12.67
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 14.8K | $120.9K | — | — | — | 0.0% |
| Q1 2026 | 16.5K | $208.6K | $12.67 | $66.3K | $21.4K | 0.0% |